Top Sell
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.60 | €50.00 | 36.612% |
| Vivoryon Therapeutics N.V. | 1 | 3 | 0 | 2 | €2.33 | - | - |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.75 | - | - |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €4.51 | €11.00 | 144.065% |
| Trevena Inc. | 2 | 26 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.55 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €6.31 | €23.82 | 277.405% |
| Rocket Pharmaceuticals Inc | 3 | 1 | 1 | 0 | ? | €26.50 | 77.198% |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.97 | €2.00 | 107.039% |
| Palatin Technologies Inc. | 0 | 1 | 0 | 0 | €0.80 | - | - |
| Organovo Holdings Inc. | 0 | 10 | 0 | 1 | €0.43 | - | - |
| Neurocrine Bioscience | 41 | 1 | 2 | 1 | €103.40 | €155.89 | 50.764% |
| Natural Alternat. | 21 | 1 | 3 | 0 | €3.94 | - | - |
| Moleculin Biotech Inc | 3 | 26 | 0 | 3 | €0.41 | €18.42 | 4393.659% |
| Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Minerva Neurosciences Inc. | 0 | 13 | 0 | 3 | €2.50 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €5.80 | €58.50 | 908.621% |
| Ironwood Pharmaceuticals | 9 | 1 | 0 | 0 | €3.74 | €18.27 | 388.503% |
| Ionis Pharmaceuticals Inc. | 27 | 6 | 1 | 0 | €34.16 | €56.83 | 66.371% |
| Inventiva SA | 1 | 1 | 0 | 1 | €1.63 | €6.00 | 267.197% |
| Intellia Therapeutics Inc | 16 | 1 | 2 | 0 | €16.39 | €58.89 | 259.312% |
| Inotiv Inc. | 4 | 1 | 1 | 0 | €1.71 | €9.93 | 480.602% |